At a time when the human genome has been sequenced advances in the life sciences seem to have great potential for human health, industry and the environment throughout Central and Eastern Europe (CEE). Still, for some, potential risks and ethical dilemmas remain, surrounding issues such as the appropriate use of GM crops, stem cells, genetic information, the nature of intellectual property and other challenges that come with EU accession. This book is the first of its kind to bring together experts from across Europe to explore the landscape of current life science policy and industrial...
At a time when the human genome has been sequenced advances in the life sciences seem to have great potential for human health, industry and the en...
GSK were caught in the perfect storm from 2008. R&D productivity was declining, costs were going up, FDA approvals were at an all time low, vital patents were expiring and successful innovation seemed to be just out of reach. Thats when the President of R&D set up a project called Innovation Sans Frontiers in an effort to create a pipeline with radical, game-chainging ideas to grow the business. This revelatory case study tracks this project over three years and identifies the key things which encourage innovation as well as highlighting the things which frustrate it. It identifies four...
GSK were caught in the perfect storm from 2008. R&D productivity was declining, costs were going up, FDA approvals were at an all time low, vital pat...
